Editor's Picks

Filter by:
  • De La Rue confident despite paper problems

    Thursday 21 Jul 2011

    Banknote and security printer De La Rue said that it remains confident in the trading outlook for the full year, despite ongoing paper problems at its Currency Division.

  • Broker tips: Kingfisher, Mitchell & Butlers, Britvic

    Thursday 21 Jul 2011

    Singer Capital Markets said that despite DIY retailer Kingfisher reporting broadly weaker-than-expected trading over the last ten weeks, full-year forecasts are likely to remain intact.

  • Developing markets boost SABMiller

    Thursday 21 Jul 2011

    Brewing giant SABMiller grew lager and soft drinks volumes by 5% in the first quarter, helped by strong growth in developing markets.

  • US preopen: Strong gains expected

    Thursday 21 Jul 2011

    The main US equity benchmarks are being called to open around 0.8% higher today. Acting as backdrop, there seems to be a certain amount of optimism as regards the outlook for a Greek rescue package. Time will tell if it is justified. A recent market report detailing some of the decisions which the EU may have taken has been pushing stocks up today.

  • Europe midday: Confusion reigns, stocks shed gains

    Thursday 21 Jul 2011

    All eyes are on Brussels today where the summit meeting of European Union leaders has just kicked off.

  • Premium tips: Petra Diamonds, BHP Billiton, AstraZeneca...

    Thursday 21 Jul 2011

    Charles Stanley reiterated its buy rating on Africa-focused diamond producer Petra Diamonds, saying that the positive trading update released on Tuesday showed that prices and production have been in line since the last announcement. “We believe that the current share price offers investors an ideal opportunity to gain exposure to an industry leading production profile.” A new target price of

  • Wincanton trades in line despite loss of Focus

    Thursday 21 Jul 2011

    Distribution group Wincanton was hit by the closure of the retailer Focus DIY in the period since 1 April, but at least won some business with big names such as Focus’s rival B&Q, the care products group Procter & Gamble and the fashion chain Jack Wills.

  • Europe broadens scope of EFSF, but with limits

    Thursday 21 Jul 2011

    European governments, in a draft statement, have given their consent to overhaul the role of the European Financial Stability Facility (EFSF) - the bailout fund, including lowered interest rate charges and an extension of debt maturities, which increases the chances of a Greece default scenario. The draft statement, obtained by The Wall Street Journal, indicates that the financial sector

  • US newspaper round-up: Express Scripts/Medco, AT&T/T-Mobile, Wells Fargo...

    Thursday 21 Jul 2011

    Express Scripts, the pharmacy benefits manager, said on Thursday that it would buy Medco Health Solutions for $29.1 billion, a major consolidation for a health care industry in transition. The company, based in St. Louis, is set to pay $71.36 in cash and stock for each Medco share, about 28 percent above Medco’s closing price on Wednesday, the New York Times reports.

  • Premium broker snap: BHP Q4 production beats UBS's expectations

    Thursday 21 Jul 2011

    UBS has adjusted its estimates for mining giant BHP Billiton, but maintained its positive stance after the group’s fourth quarter production came in slightly ahead of expectations.

  • Meggitt bladders fuel profit hopes

    Thursday 21 Jul 2011

    Meggitt, the FTSE 250 extreme engineering firm, has won an order to supply blast resistant fuel bladders to BAE Systems.

  • Vertu Motors sees sales drop

    Thursday 21 Jul 2011

    Vertu Motors, the car retailer which owns the Bristol Street Motors, Vertu Honda and Macklin Motors brands, has seen sales of new cars drop 6.6% on a like-for-like basis.

  • Great Portland sees assets rise

    Thursday 21 Jul 2011

    Great Portland Estates (GPE), the property firm, has seen a rise in the value of its portfolio by 3.8% since the end of March and net asset value per share (NAV)rise 4.2% to 375p.

  • UK public sector borrowing, slightly higher than expected

    Thursday 21 Jul 2011

    UK public sector net borrowing, excluding financial interventions, rose to £13.98bn in June, from £16.61bn the month before, according to data just out from the Office of National Statistics. Consensus estimates had been for an increase of £12.5bn. The previous month’s reading has been revised down slightly, from the original reading of £17.4bn.

  • Halfords struggling in economic headwinds

    Thursday 21 Jul 2011

    Car parts and bike retailer Halfords has seen group sales rise 0.3% in the second quarter but like for like retail sales were down 1.1% .

  • Thursday tips round-up: LSE, IPF, Playtech

    Thursday 21 Jul 2011

    There is a strong sense that the London Stock Exchange is not sure where to go next after the unexpected failure of its merger with TMX, of Canada. I do not believe that the LSE will be bid for by anyone. This leaves its shares at the top end of their trading range, up 33½p at £10.30½p yesterday and on about 13 times’ this year’s earnings. Unless you believe that a bid is in prospect, taking a

  • Colefax still cautious

    Thursday 21 Jul 2011

    Furnishing, fabrics and wallpapers designer Colefax said pre-tax for the year surged 49% after a robust performance from its decorating division but remains cautious about future trading.

  • Berlin and Paris agree on a bail-out?

    Thursday 21 Jul 2011

    Germany and France appear to have “settled their differences” over a new rescue package for Greece, according to different market reports this morning. The spokesman for Angela Merkel, Steffen Seibert, has confirmed as much to the Financial Times (FT), without providing details. The joint Franco-German position has been agreed and discussed with Jean Claude Trichet

  • Experian's Tyler picks up £733,000

    Thursday 21 Jul 2011

    A round-up of the biggest director deals today so far.

  • AstraZeneca heartened by US Brilinta approval

    Thursday 21 Jul 2011

    AstraZeneca, the Anglo-Swedish pharmaceuticals company, has won approval for its drug Brilinta in the United States.

Top of Page